Serina Therapeutics (SER) Equity Ratio (2017 - 2025)
Serina Therapeutics (SER) has disclosed Equity Ratio for 9 consecutive years, with 0.01 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 107.05% to 0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2025, down 107.05% year-over-year, with the annual reading at 0.01 for FY2025, 107.05% down from the prior year.
- Equity Ratio hit 0.01 in Q4 2025 for Serina Therapeutics, down from 0.13 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.23 in Q1 2025 to a low of 11.66 in Q4 2022.
- Historically, Equity Ratio has averaged 2.96 across 5 years, with a median of 2.8 in 2023.
- Biggest five-year swings in Equity Ratio: tumbled 2522.49% in 2021 and later surged 112.03% in 2025.
- Year by year, Equity Ratio stood at 3.77 in 2021, then tumbled by 209.59% to 11.66 in 2022, then surged by 69.11% to 3.6 in 2023, then skyrocketed by 102.1% to 0.08 in 2024, then crashed by 107.05% to 0.01 in 2025.
- Business Quant data shows Equity Ratio for SER at 0.01 in Q4 2025, 0.13 in Q3 2025, and 0.18 in Q2 2025.